Alport Syndrome: Achieving Early Diagnosis and Treatment
American Journal of Kidney Diseases, ISSN: 0272-6386, Vol: 77, Issue: 2, Page: 272-279
2021
- 92Citations
- 169Captures
- 2Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations92
- Citation Indexes92
- 92
- CrossRef27
- Captures169
- Readers169
- 169
- Mentions2
- News Mentions2
- News2
Most Recent News
Aberrant Splicing of COL4A5 Intronic Variant Contribute to the Pathogenesis of X-Linked Alport Syndrome: A Case Series
Introduction Alport syndrome (AS), also known as hereditary progressive nephritis, is an inherited glomerulopathy characterized by hematuria, proteinuria, and progressive kidney failure, with some patients
Review Description
Alport syndrome is a genetically and phenotypically heterogeneous disorder of glomerular, cochlear, and ocular basement membranes resulting from mutations in the collagen IV genes COL4A3, COL4A4, and COL4A5. Alport syndrome can be transmitted as an X-linked, autosomal recessive, or autosomal dominant disorder. Individuals with Alport syndrome have a significant lifetime risk for kidney failure, as well as sensorineural deafness and ocular abnormalities. The availability of effective intervention for Alport syndrome–related kidney disease makes early diagnosis crucial, but this can be impeded by the genotypic and phenotypic complexity of the disorder. This review presents an approach to enhancing early diagnosis and achieving optimal outcomes.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0272638620307344; http://dx.doi.org/10.1053/j.ajkd.2020.03.026; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85088366807&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/32712016; https://linkinghub.elsevier.com/retrieve/pii/S0272638620307344; https://dx.doi.org/10.1053/j.ajkd.2020.03.026
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know